Imitation May Be a Sincere Form of Treatment

Imitation May Be a Sincere Form of Treatment
/

The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

Click to view original post